1 document found, page 1 of 1

Sort by Issue Date

Development of Dl1.72, a Novel Anti-DLL1 Antibody with Anti-Tumor Efficacy agai...

Silva, G; Sales-Dias, J; Casal, D; Alves, S; Domenici, G; Barreto, C; Matos, C; Lemos, AR; Matias, AT; Kucheryava, K; Ferreira, A; Moita, MR; Braga, S

Aberrant Notch signaling is implicated in several cancers, including breast cancer. However, the mechanistic details of the specific receptors and function of ligand-mediated Notch signaling that promote breast cancer remains elusive. In our studies we show that DLL1, a Notch signaling ligand, is significantly overexpressed in ERα+ luminal breast cancer. Intriguingly, DLL1 overexpression correlates with poor pr...

Date: 2021   |   Origin: Saúde - CUF

1 Results

Queried text

Refine Results

Author





















Date


Document Type


Funding



Access rights


Resource


Subject